MedPath

Retrospective Analysis on Large Incisional Hernia in High Risk Patients

Not Applicable
Completed
Conditions
Large Incisional Hernia
Incisional Hernia
Registration Number
NCT04801394
Lead Sponsor
University of Campania "Luigi Vanvitelli"
Brief Summary

Large incisional hernia (LIH) is a challenging condition where the abdominal wall is hopelessly compromised. Nowadays the best treatment option in this particularly frail subset of patients is a major issue. The Auhtors proposed the clinical experience with an innovative approach with the composite Free Lateral Polypropylene prosthesis (FLaPp®) mesh fashioned as "neoperitoneum" analyzing its feasibility and short/medium term results.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
43
Inclusion Criteria
  • symptomatic patients with midline Large incisional hernia
Exclusion Criteria
  • lateral incisional hernias
  • collagen diseases
  • patients who recently have undergone chemotherapy and/or radiation therapy
  • patients with acquired immunodeficiency

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Mortality after FLaPp® prosthesisOne month

Rate of posoperative mortality after FLaPp® prosthesis

Evaluation of pain after FLaPp® prosthesisone month

Evaluation of postoperative pain through Visual Analague Scale

Early surgical outcome of FLaPp® prosthesis classified according to Clavien Dindo Classificationone month

evaluation of feasibility of FLaPp® prosthesis in patients affected by LIH by the assessment of postoperative morbidity classified according to Clavien Dindo Classification

Secondary Outcome Measures
NameTimeMethod
Patients' satisfatcion after FLaPp® prosthesis36 months

Evaluated through the so-called 36 items Short-Form health survey

incisional hernia recurrence at medium term36 months

assessment of postoperative recurrence after 36 months evaluated with clinical outcpatient control and CT scan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.